SMARCA2 inhibitors (Arvinas/Genentech)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameSMARCA2 inhibitors (Arvinas/Genentech)
Drug Alias NameSMARCA2 and 4 inhibitors (Arvinas/Genentech)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSMARCA4 inhibitorsProbable global transcription activator SNF2L2 inhibitors
TargetsProbable global transcription activator SNF2L2Transcription activator BRG1
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesArvinas Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesArvinas IncGenentech Inc
Active IndicationsN/A
Inactive IndicationsCarcinoma, Non-Small-Cell LungNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A